Cargando…

Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities?

The arginine methyltransferase PRMT5 has been increasingly associated with cancer development. Here we describe our recent findings that PRMT5 is a critical regulator of breast cancer stem cell survival via the epigenetic regulation of FOXP1. Consequently, PRMT5 inhibitors could potentially eradicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Kelly, Davies, Clare C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Author's Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964458/ https://www.ncbi.nlm.nih.gov/pubmed/29876520 http://dx.doi.org/10.1080/23723556.2018.1441628

Ejemplares similares

Dual role of PRMT1-dependent arginine methylation in cellular responses to genotoxic stress
por: Giambruno, Roberto, et al.
Publicado: (2020)

Regulation of tumor-associated high-endothelial venules by dendritic cells: A new opportunity to promote lymphocyte infiltration into breast cancer?
por: Martinet, Ludovic, et al.
Publicado: (2013)

BMP2, a key to uncover luminal breast cancer origin linked to pollutant effects on epithelial stem cells niche
por: Chapellier, Marion, et al.
Publicado: (2015)

Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
por: Cioffi, Michele, et al.
Publicado: (2012)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

The CCL5/CCR5 axis promotes metastasis in basal breast cancer
por: Velasco-Velázquez, Marco, et al.
Publicado: (2013)

New control of the senescence barrier in breast cancer
por: Costa, Tânia D. F., et al.
Publicado: (2020)

DDR1 inhibition as a new therapeutic strategy for colorectal cancer
por: Sirvent, Audrey, et al.
Publicado: (2018)

Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
por: Mao, Chih-Ping, et al.
Publicado: (2014)

ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018)

Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression
por: Demers, Mélanie, et al.
Publicado: (2013)

The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone
por: Slaney, Clare Y., et al.
Publicado: (2013)

The other face of TLR3: A driving force of breast cancer stem cells
por: Jia, Deyong, et al.
Publicado: (2015)

New link between the RNA polymerase II-CTD and replication stress
por: Landsverk, Helga B., et al.
Publicado: (2021)

Gut microbiota and colon cancer: the carbohydrate link
por: Belcheva, Antoaneta, et al.
Publicado: (2014)

Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy
por: Issa-Nummer, Yasmin, et al.
Publicado: (2014)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
por: Mahmoud, Sahar, et al.
Publicado: (2012)

Functional characterization of ENPP1 reveals a link between cell cycle progression and stem-like phenotype in glioblastoma
por: Bageritz, Josephine, et al.
Publicado: (2014)

Linking apoptosis to cancer metabolism: Another missing piece of JuNK
por: Papa, Salvatore, et al.
Publicado: (2016)

Targeting MYC through WDR5
por: Thomas, Lance R., et al.
Publicado: (2020)

The adenosinergic system in cancer: Key therapeutic target
por: Sorrentino, Rosalinda, et al.
Publicado: (2013)

Sweet connections: O-GlcNAcylation links cancer cell metabolism and survival
por: Ferrer, Christina M, et al.
Publicado: (2014)

Strategies for purging CD96(+) stem cells in vitro and in vivo: New avenues for autologous stem cell transplantation in acute myeloid leukemia
por: Staudinger, Matthias, et al.
Publicado: (2013)

Escape from senescence: revisiting cancer therapeutic strategies
por: Zampetidis, Christos P., et al.
Publicado: (2022)

Cytotoxic T lymphocytes: Sniping cancer stem cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2012)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
por: Husain, Zaheed, et al.
Publicado: (2013)

The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020)

Prostate cancer: Important steps and considerations in the design of therapeutic vaccines
por: McArdle, Stephanie EB, et al.
Publicado: (2014)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
por: Rathore, Richa, et al.
Publicado: (2021)

When defense turns into attack: Antiviral cytidine deaminases linked to somatic mutagenesis in HPV-associated cancer
por: Henderson, Stephen, et al.
Publicado: (2014)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

Stress-induced metastatic niches in breast cancer
por: Oskarsson, Thordur
Publicado: (2020)

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

Regulation of cancer stem-like cell differentiation by Smac mimetics
por: Fulda, Simone
Publicado: (2014)

Linking H1 with chromatin and growth control
por: Munro, Shonagh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_22vteqpo0i5emd4234kgi43ju0